Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study
Sign Up to like & getrecommendations! Published in 2018 at "Neurobiology of Disease"
DOI: 10.1016/j.nbd.2018.04.015
Abstract: Plasma total and nervous system derived exosomal (NDE) α-synuclein have been determined as potential biomarkers of Parkinson's disease (PD). To explore the utility of plasma α-synuclein in the prodromal phase of PD, plasma total and… read more here.
Keywords: associated risk; plasma; synuclein; nde synuclein ... See more keywords